Taiho Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taiho Pharmaceutical Co., Ltd., explained in plain language.
-
New drug trial targets Cancer's genetic weakness
Disease control Recruiting nowThis clinical trial is testing a new oral drug called TAS0953/HM06 for people with advanced solid tumors that have specific changes in the RET gene. The study aims to find the safest and most effective dose and see if the drug can shrink tumors. It is enrolling adults with variou…
Phase: PHASE1, PHASE2 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Testing a pill to replace injections for blood disorder treatment
Disease control Recruiting nowThis early-stage study is testing a new oral pill combination (ASTX030) for patients with myelodysplastic syndrome (MDS), a bone marrow disorder. The main goal is to find a pill dose that works as well as the current standard injection treatment. Researchers will enroll about 40 …
Phase: PHASE1 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC